VRTX vs ABBV
Vertex Pharmaceuticals vs AbbVie — AI-powered side-by-side comparison
| Metric | VRTX | ABBV |
|---|---|---|
| AI Score | 60 | 56 |
| Price | $498.39 | $252.68 |
| P/E Ratio | 30.05× | 123.83× |
| ROE | 23.9% | 95.6% |
| Revenue Growth YoY | 10.1% | 9.5% |
| Gross Margin | 86.2% | 72.0% |
| Debt / Equity | 0.01× | 20.19× |
| Dividend Yield | — | 2.7% |
| RSI (14) | 65.2 | 68.1 |
| Beta | 0.2908 | 0.2714 |
| Expected Upside | +1.5% | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
VRTX Full Analysis
ABBV Full Analysis